Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders
Authors:
- Ignazio Stefano PirasIgnazio Stefano Piras
- Stefano GabrieleSGStefano Gabriele
- Laura AltieriLALaura Altieri
- Federica LombardiFLFederica Lombardi
- Roberto SaccoRSRoberto Sacco
- Carla LintasCLCarla Lintas
- Barbara ManziBMBarbara Manzi
- Paolo CuratoloPCPaolo Curatolo
- Maria NobileMNMaria Nobile
- Catia RigolettoCRCatia Rigoletto
- Massimo MolteniMMMassimo Molteni
- Antonio M. PersicoAPAntonio M. Persico
Open Access
- 22 January 2021
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 10 (2) , 164
Abstract
Organophosphate compounds (OPs) interfere with neurodevelopment and are neurotoxic for humans and animals. They are first biotransformed to the more toxic oxon form, and then hydrolyzed to specific metabolites by the enzyme paraoxonase/arylesterase, encoded by the gene PON1 located on human chr. 7q21.3. In autism spectrum disorder (ASD) and in attention-deficit/hyperactivity disorder (ADHD), a correlation between OP exposure and disease onset has been reported. In this case-control study, we aimed to replicate our previous work showing reduced levels of serum PON1 arylesterase activity in Italian and Caucasian-American ASD samples, and to extend our analysis to other neurodevelopmental disorders, namely ADHD and developmental language disorder (DLD), also known as specific language impairment (SLI). The arylesterase activity, measured using standard spectrophotometric methods, is significantly reduced in the ADHD, and not in the ASD sample compared with the controls. Our previous results seemingly stem from spuriously high arylesterase levels in the former control sample. Finally, genotyping SNPs rs705379 and rs662 using TDI-FP, a significant effect of rs705379 alleles on the serum arylesterase activity is observed in all of the subgroups tested, regardless of diagnosis, as well as a lack of association between PON1 gene polymorphisms and ASD/ADHD susceptibility in the Italian population. In summary, the serum arylesterase activity is reduced in children and adolescents with ADHD, and this reduction is not due to the functional PON1 gene variants assessed in this study. Based on previous literature, it may more likely reflect enhanced oxidative stress than specific genetic underpinnings.Keywords
Funding Information
- Ministero della Salute (RFPS-2007-5-640174)
- Ministero dell’Istruzione, dell’Università e della Ricerca (Prin n2006058195, Prin n. 2008BACT54_002)
This publication has 47 references indexed in Scilit:
- Organophosphate Pesticide Exposure and Attention in Young Mexican-American Children: The CHAMACOS StudyEnvironmental Health Perspectives, 2010
- Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and WindowsMolecular Ecology Resources, 2010
- PON1 multitasks to protect healthProceedings of the National Academy of Sciences, 2008
- Developmental neurotoxicity of low dose diazinon exposure of neonatal rats: Effects on serotonin systems in adolescence and adulthoodBrain Research Bulletin, 2008
- Maternal Residence Near Agricultural Pesticide Applications and Autism Spectrum Disorders among Children in the California Central ValleyEnvironmental Health Perspectives, 2007
- Exposure to Organophosphates Reduces the Expression of Neurotrophic Factors in Neonatal Rat Brain Regions: Similarities and Differences in the Effects of Chlorpyrifos and Diazinon on the Fibroblast Growth Factor SuperfamilyEnvironmental Health Perspectives, 2007
- Organophosphate Pesticide Exposure and Neurodevelopment in Young Mexican-American ChildrenEnvironmental Health Perspectives, 2007
- Impact of Prenatal Chlorpyrifos Exposure on Neurodevelopment in the First 3 Years of Life Among Inner-City ChildrenPediatrics, 2006
- Current issues in organophosphate toxicologyClinica Chimica Acta, 2006
- High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autismLife Sciences, 2006